As a prominent leader in the President’s Precision Medicine Initiative and one of the top recipients of grants from the National Cancer Institute, Michigan Medicine is one of the most exciting places today to advance precision cancer treatment.
Our top priority is to recruit world-class research investigators to help us fast-track promising research and translate laboratory breakthroughs into the clinical arena.
The more researchers test their creative ideas, the more likely we are to find a solution that works. Michigan is a place where ideas take flight and collaboration powers breakthroughs. With a shared commitment and a powerful combined legacy, we will transform lives for children with pediatric brain tumors and those who love them.
Current Faculty Openings
Email us at firstname.lastname@example.org to explore opportunities to join our research faculty.
Pediatric Neurology Neuro-oncology Faculty Position
Michigan Medicine – the University of Michigan
The Department of Pediatrics is seeking a clinical neuro-oncologist in the Division of Pediatric Neurology at the University of Michigan in Ann Arbor. The Division currently includes 21 faculty members with diverse clinical and scholarly interests. We work very closely with Pediatric Oncology/Bone Marrow Transplantation, Pediatric Neurosurgery, Radiation Oncology, and Pediatric Genetics.
The Pediatric Oncology and Neuro-Oncology Program at Michigan Medicine is a tertiary referral center for the state of Michigan and nearby upper mid-western states. It is home to the state’s only Pediatric Phase-I Program, and a state of the art Pediatric Precision Oncology Program. Our Pediatric Neuro-Oncology program sees 40-50 newly diagnosed pediatric and young adult brain tumor patients annually. There is a designated neuro-oncology nurse practitioner. The Pediatric Neuro-Oncology Program also has a neurofibromatosis and tuberous sclerosis clinic.
Our program is an active member institution of the Children’s Oncology Group Phase I consortium and the Pacific Pediatric Neuro-Oncology Consortium. We participate in many industry-sponsored clinical research trials, including those for patients with neurofibromatosis. The Pediatric Neuro-Oncology program participates in a precision oncology program (PEDS-MIONCOSEQ) in collaboration with Michigan Center for Translational Pathology (MCTP). In addition, we have several investigator-initiated early phase precision neuro-oncology trials. Our program is home to the exciting Pediatric Brain Tumor Research Initiative and the Chad Carr Pediatric Brain Tumor Center. Our strong basic research program focuses on DIPGs and other brain tumors.
The Pediatric Neurology Division at Mott Children’s Hospital provides comprehensive diagnostic services and treatment for children with neurologic disorders. Clinics and inpatient care are provided at Mott Children’s Hospital as well as several satellite clinics. The Division is supported by five nurse practitioners, three ketogenic dieticians, an epilepsy care coordinator, nurses, and social workers. Our research assistants support both multicenter and local clinical research studies. Pain psychologists work closely with our headache patients. The University of Michigan provides outstanding environments for clinical care, for student and resident education, and for translational, health services, and basic research.
Candidates must be board certified or eligible for certification by the ABPN with Special Qualification in Child Neurology, and must be US citizens or permanent US residents who are eligible for medical licensure in Michigan
This position is posted as Clinical Instructor/Clinical Assistant Professor/Clinical Associate Professor/Clinical Professor. Rank of selected candidate is dependent upon qualifications.
The University of Michigan, the Department of Pediatrics, and the Division of Pediatric Neurology are committed to having our staff and faculty represent a breadth of perspectives to better serve both our patients and the University community. Therefore, Michigan Medicine seeks to recruit and retain a diverse workforce as a reflection of our commitment to serve the diverse people of Michigan and to maintain the excellence of the University. We welcome applications from anyone who would bring additional dimensions to the University’s research, teaching, and clinical mission, including women, members of minority groups, protected veterans, and individuals with disabilities. The Department of Pediatrics, like the University of Michigan as a whole, is committed to a policy of nondiscrimination and equal opportunity for all persons and will not discriminate against any individual because of race, color, national origin, age, marital status, sex, sexual orientation, gender identity, gender expression, disability, religion, height, weight, or veteran status. The University of Michigan is an Equal Employment Opportunity/Affirmative Action Employer.
COVID-19 vaccinations are now required for all University of Michigan students, faculty and staff across all three campuses, including Michigan Medicine, by the start of the fall term on August 30, 2021. This includes those working or learning remotely. More information on this policy is available on the Campus Blueprint website or the U-M Dearborn and U-M Flint websites.
Interested physicians should send their personal statement and CV to:
Steven Leber, MD, PhD
Division Director, Pediatric Neurology
12-733D Mott Children’s Hospital
Ann Arbor, MI 48109-4279
Inaugural DIPG Endowed Professor of Pediatric Oncology - Faculty Position
The Department of Pediatrics, C.S. Mott Children’s Hospital, and the Rogel Cancer Center at Michigan Medicine are recruiting a physician scientist to serve as the inaugural DIPG Endowed Professor of Pediatric Oncology. Faculty appointment will be at the Associate Professor or Full Professor rank on the Instructional (Tenure) track at Michigan Medicine, contingent upon qualifications, department sponsorship, clinical expertise, and research training. This position is open to any candidate with research expertize in pediatric brain tumors with specific emphasis on DIPG. Candidate may have completed training in any of the following areas: Pediatrics, Oncology, Neurology, Neurosurgery, Radiation Oncology, Radiology, Genetics or Pathology.
The successful candidate will have an established track record of research in Pediatric Neuro-oncology with a focus on the pediatric cancer Diffuse Intrinsic Pontine Glioma (DIPG) and an appropriate record of scholarly publications and extramural funding. Evidence of national or international recognition and a commitment to developing an innovative, collaborative academic program in pediatric brain tumor research at the University of Michigan are essential. Pediatric oncology physician-scientists who have predominantly worked on other childhood brain tumors, but who seek to transition to focus predominantly on DIPG or Physician-scientists who have largely emphasized work in brain development and/or adult brain tumors, but who seek to transition to focus predominantly on DIPG and other brain tumors in children are also encouraged to apply. Physician-scientist candidates may or may not be actively practicing in their clinical specialty based on their personal preference.
The University of Michigan Medical School hosts 29 departments and 15 major centers and institutes at the forefront of innovation across the entire research spectrum. Our faculty and staff are widely recognized for team science, across campus, across the country, and around the world. The University of Michigan consistently ranks in the top 10 NIH funded medical schools in the nation and is a recognized leader in cancer research and drug discovery. Faculty in the Division of Pediatric Hematology/Oncology are members of the Rogel Cancer Center, which connects collaborative research teams across the University and beyond, and coordinates all levels of multidisciplinary research including basic, translational, and clinical care. Close interactions with the Schools of Engineering and Pharmacy and with the biotech and pharmaceutical industries facilitate the development of innovative technologies, drugs and drug delivery systems, and enable expeditious early-phase testing of new potential cancer treatments.
The Pediatric Oncology and Neuro-Oncology Program at Michigan Medicine is a tertiary referral center for the state of Michigan and nearby upper mid-western states. It is home to the state’s only Pediatric Phase-I Program, and a state of the art Pediatric Precision Oncology Program. Our Pediatric Oncology program sees 140 new cancer diagnoses annually, including 35-40 newly diagnosed pediatric and young adult brain tumor patients. The Pediatric Hematology/Oncology/Bone Marrow Transplant Program is housed in the state of the art C.S. Mott Children's Hospital and is staffed by 16 physicians, 6 fellows and 16 nurse practitioners. Our program is an active member institution of the Children’s Oncology Group Phase I consortium, COG Phase II-III treatment center and PBMTC. The Pediatric Oncology program has focused basic, translational and clinical research programs in sarcomas including SARC SPORE, neuroblastoma, neuro-oncology, survivorship and Pediatric BMT. The Division implemented a precision oncology program (PEDS-MIONCOSEQ) in collaboration with Michigan Center for Translational Pathology (MCTP). In addition, we have several investigator-initiated early phase clinical trials in neuroblastoma, brain tumors, precision oncology pediatric BMT and also participate in the NANT and TACL consortiums.
Our program is home to exciting Pediatric Brain Tumor Research Initiative and hosts a multidisciplinary multi-institutional Pediatric Brain Tumor Precision Oncology Tumor Board and Solid Tumor Oncology Program (MSTOP) tumor board in collaboration with the Departments of Neurosurgery, Neuro-Pathology, Radiation Oncology, Pediatric Surgery, Genetics and Pediatric Radiology.
The incumbent will be expected to establish an independent investigative program, focusing on DIPG & other related pediatric brain tumors. The candidate will spend the majority of effort developing and advancing therapies to treat childhood brain cancers. Appropriate laboratory, administrative office and support staff and protected time will be provided. S/he will be installed as the inaugural DIPG Endowed Professor of Pediatric Oncology. This professorship will provide unrestricted support to the investigator’s research enterprise on an annual basis. The investigator will be expected to support and mentor research efforts of the faculty, fellows and graduate programs of Michigan Medicine and provide and advance collegial research collaborations within the academic departments and cancer center.
Interested candidates should submit a curriculum vitae and a cover letter detailing experience and future interests to:
Dr. Donna Martin
Donita B. Sullivan, M.D. Research Professor of Pediatrics
Professor and Interim Chair, Department of Pediatrics
The University of Michigan
D3202 Medical Professional Building
1500 E. Medical Center Drive, SPC 5718
Ann Arbor, MI 48109-5718
Dr. Eric Fearon
Director, Rogel Cancer Center
1500 East Medical Center Drive
Ann Arbor, MI 48109